Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/176142
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Alcaraz Asensio, Antonio | - |
dc.contributor.author | Rodríguez Antolín, Alfredo | - |
dc.contributor.author | Carballido Rodríguez, Joaquín | - |
dc.contributor.author | Castro Díaz, David | - |
dc.contributor.author | Esteban Fuertes, Manuel | - |
dc.contributor.author | Cózar Olmo, José M. | - |
dc.contributor.author | Ficarra, Vincenzo | - |
dc.contributor.author | Medina López, Rafael | - |
dc.contributor.author | Fernández Gómez, Jesús M. | - |
dc.contributor.author | Angulo, Javier C. | - |
dc.contributor.author | Medina Polo, José | - |
dc.contributor.author | Brenes Bermúdez, Francisco J. | - |
dc.contributor.author | Molero García, José M. | - |
dc.contributor.author | Fernández Pro Ledesma, Antonio | - |
dc.contributor.author | Manasanch, José | - |
dc.contributor.author | The QUALIPROST Study Group | - |
dc.date.accessioned | 2021-04-09T13:18:21Z | - |
dc.date.available | 2021-04-09T13:18:21Z | - |
dc.date.issued | 2020-09-09 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | http://hdl.handle.net/2445/176142 | - |
dc.description.abstract | To investigate whether tamsulosin (TAM) and the hexanic extract of Serenoa repens (HESr) are more effective in combination than as monotherapy in men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH). Subset analysis of data from a 6-month, multicenter observational study. Patients received either tamsulosin (0.4 mg/day) or HESr (320 mg/day) alone or in combination. Primary endpoints were change in symptoms and quality of life. Tolerability was also assessed. Seven hundred and nine patients were available for intention to treat (ITT) analysis, 263 treated with tamsulosin, 262 with HESr, and 184 with TAM + HESr. After 6 months, International Prostate Symptom Score (IPSS) scores improved by a mean (standard deviation) of 7.2 (5.0) points in the TAM + HESr group compared to 5.7 (4.3) points with TAM alone and 5.4 (4.6) points with HESr (p < 0.001). Quality of life showed greatest improvement with combination therapy (p < 0.02). Adverse effects were reported by 1.9% of patients receiving HESr, 13.3% receiving TAM, and 12.0% receiving TAM + HESr (p < 0.001). In men with moderate/severe LUTS/BPH, combination treatment with TAM + HESr produced more effective symptom relief and greater improvement in quality of life than with either treatment alone, with acceptable tolerability. | - |
dc.format.extent | 14 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/jcm9092909 | - |
dc.relation.ispartof | Journal of Clinical Medicine, 2020, vol. 9, num. 9, p. 2909 | - |
dc.relation.uri | https://doi.org/10.3390/jcm9092909 | - |
dc.rights | cc-by (c) Alcaraz Asensio, Antonio et al., 2020 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | - |
dc.source | Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques) | - |
dc.subject.classification | Aparell urinari | - |
dc.subject.classification | Hiperplàsia suprarenal congènita | - |
dc.subject.classification | Terapèutica | - |
dc.subject.other | Urinary organs | - |
dc.subject.other | Congenital adrenal hyperplasia | - |
dc.subject.other | Therapeutics | - |
dc.title | Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 707673 | - |
dc.date.updated | 2021-04-09T13:18:21Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 32917008 | - |
Appears in Collections: | Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
707673.pdf | 938.29 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License